ZEUS Scientific Acquires Synthetic Peptides from Sheba Medical Center's Tech Transfer Co.
October 29, 2021 08:30 ET | ZEUS Scientific
BRANCHBURG, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- ZEUS Scientific has obtained exclusive, worldwide rights to the use of these synthetic peptides as targets of disease-specific autoantibodies in...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
July 20, 2021 09:00 ET | Sorrento Therapeutics, Inc.
China National Medical Product Administration (NMPA) has granted Mabpharm approval to market INFLIXIMAB biobetter in China.Sorrento holds commercialization rights outside of China and intends to meet...
I Have Ankle Arthritis – Now What? Rosemont, Ill., May 27, 2021 (GLOBE NEWSWIRE) -- May is National Arthritis Awareness Month, a time to bring attention to a disease that affects one in four adults in the United States. Arthritis can...
Nurix.png
Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress
May 21, 2021 07:00 ET | Nurix Therapeutics, Inc.
SAN FRANCISCO, May 21, 2021 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that preclinical...
CWHP_Logo_Horizontal.jpg
The Center for Workforce Health and Performance and National Association of Worksite Health Centers Release Report to Help Employers and Insurers Manage Musculoskeletal Conditions
April 22, 2021 08:03 ET | The Center for Workforce Health and Performance
OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are estimated to cost insurers and employers about $6.3 billion...
“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During September’s Rheumatic Disease Awareness Month
September 02, 2020 11:29 ET | American College of Rheumatology
ATLANTA, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and Simple Tasks™ will recognize the fifth annual Rheumatic Disease Awareness Month (RDAM) this September with...
Premium Hemp CBD manufacturer Tree of Life Seeds partners with the Arthritis Foundation
October 22, 2019 11:16 ET | Arkansas Arthritis Foundation
Little Rock, Arkansas, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The Arkansas Arthritis Foundation is partnering with Tree of Life Seeds, Arkansas-based hemp genetics and CBD product manufacturer, to raise...
Allsup Supports U.S. Pain Foundation in Bringing Attention to Chronic Pain during National Pain Awareness Month
September 23, 2019 11:57 ET | Allsup
Belleville, Illinois, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company, remains committed to supporting the significant contributions of the U.S....
Sandoz Canada receives Health Canada approval for Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis (PsA) in Adult Patients
January 21, 2019 08:31 ET | Sandoz Canada
Boucherville, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic arthritis (PsA) in adult patients.Up to...
National Rheumatology and Psoriasis Organizations Release Joint Guideline for Treating Psoriatic Arthritis
December 03, 2018 17:04 ET | American College of Rheumatology
Atlanta, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA)...